Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours-Reference-Cited by-同舟云学术

Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours

Published:2023-07 Issue: Volume:188 Page:39-48
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hernando Jorge,Roca-Herrera Maria,García-Álvarez Alejandro,Raymond Eric,Ruszniewski Philippe,Kulke Matthew H.,Grande Enrique,García-Carbonero Rocío,Castellano Daniel,Salazar Ramón,Ibrahim Toni,Teule Alex,Alonso Vicente,Fazio Nicola,Valle Juan W.,Tafuto Salvatore,Carmona Ana,Navarro Victor,Capdevila Jaume

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Gender medicine and oncology: report and consensus of an ESMO workshop;Wagner;Ann Oncol,2019

2. An evaluation of sex- and gender-based analyses in oncology clinical trials;Hall;J Natl Cancer Inst,2022

3. Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials;Unger;J Clin Oncol,2022

4. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary;Pavel;Neuroendocrinology,2016

5. Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications;Lauricella;Front Oncol,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study;Cancers;2024-06-11

2. Corrigendum to “Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours” [Eur J Cancer 188 (2023) 39–48];European Journal of Cancer;2024-05

3. A highly efficient [3+2] cyclization between 4-aminopyridinones and acenaphthenequinone: Access to novel acenaph-tho[1′,2':4,5]pyrrolo[3,2-c]pyridin-11-ones;Tetrahedron;2024-01

4. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms;Endocrine-Related Cancer;2023-12-20

5. Sex differences in multikinase inhibitor toxicities;Reactions Weekly;2023-05-27